In the news | Fast Company
ImmuneCODE named to Fast Company “Health: Next Big Things in Tech” list
Microsoft and Adaptive Biotech - For using data to create a test for past COVID-19 infection | The tech giant teamed up with Adaptive Biotech to create ImmuneCODE, an open-source database of immune responses to COVID-19, which they used to…
In the news | The Seattle Times
Screening to detect prior coronavirus infections launched by Adaptive Biotech, with Microsoft’s help
Adaptive Biotechnologies launched a test that uses machine-learning technology from Microsoft to detect prior coronavirus infections, aiming to fill an important gap left by standard antibody screening. The screening, called T-Detect COVID, searches for T-cell responses against the disease, rather…
In the news | BioSpace
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
SEATTLE, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced the launch…
In the news | Adaptive Biotech
T Cell Testing Outperforms Antibody Testing in Determining Prior COVID-19 Infection
COVID-19 rates are at an all-time high. With no singular containment strategy underway in the U.S., it has become more critical than ever to understand who has previously been infected by the virus, whether or not they displayed symptoms. Traditional…
In the news | Forbes
Adaptive Biotechnologies Leverages Microsoft Azure In Search For COVID-19 Answers
The United States just passed a very ominous milestone in the COVID-19 pandemic. As almost every state struggles to contain a dramatic rise in COVID-19 cases, the United States has now lost more than 250,000 people to this virus. The…
In the news | New York Times
New Type of Test May Better Discern Immunity to the Coronavirus
A new type of test can detect a person’s immune response to the coronavirus better than a widely used antibody test, according to research released on Tuesday. The test, if authorized by the Food and Drug Administration, would be the…
In the news | Microsoft News Center
Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus
SEATTLE and REDMOND, Wash. — June 11, 2020 — Adaptive Biotechnologies Corp. (Nasdaq: ADPT) on Thursday launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT) to begin sharing one of the largest, most detailed views of the immune response to COVID-19 in…
In the news | Microsoft News Center
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
SEATTLE and REDMOND, Wash. — March 20, 2020 — Adaptive Biotechnologies Corp. (Nasdaq: ADPT) and Microsoft Corp. (Nasdaq: MSFT) on Friday announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19.…
In the news | Microsoft Industry Blog
Every immune system has a story to tell; the key is knowing how to listen
Decoding nature's antigen map requires immunological data of a scale never-before generated, coupled with new algorithmic approaches to modeling how T-cells bind to antigens.